Jean-Pierre Sommadossi, President, CEO, and Chairman: Atea Pharmaceuticals AVIR Sell · Filed 24/09/19

Trade details

Type: Insider sale
Amount: $7,364
Shares · price: 1,841 sh · $4.00 a share
Held after: 5,866,025 sh
Stock: Atea Pharmaceuticals AVIR
Person: Jean-Pierre SommadossiPresident, CEO, and Chairman
Trade date: 24/09/19
Filed: 24/09/19
Days to filing: 0 days

Sold under 0.1% of holdings

Share of holding sold: under 0.1%

Atea Pharmaceuticals trades, last 26 weeks

What else happened in Atea Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/08/20~24/10/19

Jean-Pierre Sommadossi's recent trades

Jean-Pierre SommadossiPresident, CEO, and Chairman
Sell10b5-1 planAtea Pharmaceuticals
Sell10b5-1 plan
Atea Pharmaceuticals
AVIR
$137.5K
33,941 sh
$137.5K
Filed 24/09/19
Traded 24/09/17
Jean-Pierre SommadossiPresident, CEO, and Chairman
Sell10b5-1 planAtea Pharmaceuticals
Sell10b5-1 plan
Atea Pharmaceuticals
AVIR
$89.4K
22,187 sh
$89.4K
Filed 24/09/19
Traded 24/09/18
Jean-Pierre SommadossiPresident, CEO, and Chairman
Sell10b5-1 planAtea Pharmaceuticals
Sell10b5-1 plan
Atea Pharmaceuticals
AVIR
$4,024
1,006 sh
$4,024
Filed 24/06/07
Traded 24/06/05
Jean-Pierre SommadossiPresident, CEO, and Chairman
Sell10b5-1 planAtea Pharmaceuticals
Sell10b5-1 plan
Atea Pharmaceuticals
AVIR
$219.1K
56,910 sh
$219.1K
Filed 24/02/02
Traded 24/02/01

Jean-Pierre Sommadossi, Chairman — sold $7,364 of Atea Pharmaceuticals AVIR · under 0.1% of holdings · 10b5-1 plan | Whalegun